Paradigm Health
Equitable access to clinical trials for any patient, anywhere
- Founded
- 2021
- Business Model
- B2B
- Website
- paradigm.inc
- Last Round
- SeedJan 2021
About
Paradigm Health is an AI-native healthcare technology company rebuilding the clinical research ecosystem by creating a platform that enables equitable access to clinical trials for all patients, anywhere. Incubated by ARCH Venture Partners in 2021, the company combines a global provider network with an AI-powered research platform to reduce barriers to trial participation for both patients and healthcare providers. Paradigm Health has raised over $200M in Series A funding co-led by ARCH Venture Partners and General Catalyst, with investors including GV, Lux Capital, F-Prime, and Mubadala.
Summary
Paradigm Health is a Life Sciences company, founded in 2021. Its most recent funding was a Seed round in Jan 2021.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.